ARTICLE
4 July 2025

HHS Partners With Plans To Announce Improvements On Prior Authorizations

MP
Manatt, Phelps & Phillips LLP

Contributor

Manatt is a multidisciplinary, integrated national professional services firm known for quality and an extraordinary commitment to clients. We are keenly focused on specific industry sectors, providing legal and consulting capabilities at the very highest levels to achieve our clients’ business objectives.
On June 23, HHS Secretary Kennedy and CMS Administrator Dr. Mehmet Oz held a roundtable with health insurance companies to discuss a new pledge to "streamline and improve the prior authorization processes...
United States Food, Drugs, Healthcare, Life Sciences

On June 23, HHS Secretary Kennedy and CMS Administrator Dr. Mehmet Oz held a roundtable with health insurance companies to discuss a new pledge to "streamline and improve the prior authorization processes for Medicare Advantage (MA), Medicaid Managed Care, Health Insurance Marketplace and commercial plans." Endorsed by a number of private health plans, the pledge includes six key reforms:

  1. Standardizing electronic prior authorization submissions using Fast Healthcare Interoperability Resources (FHIR®)-based application programming interfaces.
  2. Reducing the scope of claims subject to prior authorization by January 1, 2026.
  3. Ensuring continuity of care by honoring existing authorizations for up to 90 days during insurance transitions.
  4. Enhancing transparency and communication around authorization decisions and appeals.
  5. Expanding real-time responses to 80 percent of electronic prior authorization requests by 2027, to minimize delays in care.
  6. Ensuring medical professionals review all clinical denials.

Many of the elements of the pledge are either already required, already happening, or are things that payors have sought in the past. Despite this, the announcement underscores the Administration's interest in continuing to encourage "private sector reforms" that may be complementary to the Administration's regulatory agenda, noting that HHS and CMS may "pursue additional regulatory actions if necessary."

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More